Adenocarcinoma of ovary

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →

At a Glance

Live from database

1FDA treatments

9Recruiting trials

Regulatory Watchboard

10 events

Sep 2026Efficacy and Safety of Sacituzumab in Patients With OCCC After Immunotherapy Progression

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

TrialNOT YET RECRUITING

Jun 2026Assessment of Adherence to Remotely Monitored Physical Activity Tracked on a Smartwatch, and Its Impact on Reducing Fatigue 3 Months After Adjuvant Chemotherapy for Cancer

Centre Antoine Lacassagne — NA

TrialNOT YET RECRUITING

Mar 2026[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Blue Earth Diagnostics — PHASE1, PHASE2

TrialRECRUITING

Mar 2026Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

GE Healthcare — PHASE2, PHASE3

TrialNOT YET RECRUITING

Feb 2026Anti-Ly6E Exatecan ADC M7437 in Advanced Solid Tumors

EMD Serono Research & Development Institute, Inc. — PHASE1

TrialRECRUITING

Feb 2026DETERMINE Trial Treatment Arm 07: Dabrafenib in Combination With Trametinib in Adult, Paediatric and Teenage/Young Adult Patients With BRAF V600 Mutation-Positive Cancers.

Cancer Research UK — PHASE2, PHASE3

TrialNOT YET RECRUITING

Feb 2026SL-28 for Advanced Solid Tumours

Second Life Therapeutics — PHASE1, PHASE2

TrialNOT YET RECRUITING

Jan 2026Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.

Jules Bordet Institute

TrialRECRUITING

Dec 2025The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.

New Phase Ltd. — NA

TrialRECRUITING

Nov 2025Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of MT-304 in Adults With Advanced HER2-Expressing Solid Tumors

Myeloid Therapeutics — PHASE1

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

FINANCIAL LANDSCAPE SUMMARY

0

Total programs

No financial assistance programs currently listed for Adenocarcinoma of ovary.
Check the disease page for updates →

Approved Treatments

1 FDA-approved

CYRAMZA

(ramucirumab)Orphan drugstandard

Eli Lilly and Company

Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]

12.1 Mechanism of Action Ramucirumab is a VEGFR2 antagonist that specifically binds VEGFR2 and blocks binding of VEGFR ligands, VEGF-A, VEGF-C, and VE...

View full treatment details on disease page →

Clinical Trial Landscape

9 active trials

1Phase 3

3Phase 2

1Phase 1

3Unknown

1PHASE1, PHASE2

9Total recruiting

Search clinical trials for Adenocarcinoma of ovary →

Recent News & Research

No recent news articles indexed yet for Adenocarcinoma of ovary.
Search PubMed for Adenocarcinoma of ovary →

Browse all Adenocarcinoma of ovary news →

Specialist Network

Top 6 by expertise

Anurag Singh

Roswell Park Cancer Institute

Score 337 trials398 pubs

Ramez N Eskander, M.D

NRG Oncology

📍 ENCINITAS, CA

Score 192 trials

John K Chan

NRG Oncology

Score 163 trials103 pubs

BioNTech Responsible Person

BioNTech SE

Score 1318 trials

Mark Jones, MD

Incyte Corporation

Score 126 trials

Teemu Murtola, MD PhD Prof

Tampere University Hospital

Score 111 trial

View all Adenocarcinoma of ovary specialists →

Quick Actions

View Disease Page

Full profile, treatments, community

Search Clinical Trials

Find recruiting studies now

Find Specialists

Ranked by expertise & trials

Financial Assistance

Copay cards, PAPs, grants

Latest News

Research, approvals & updates

Browse All Diseases

11,000+ rare disease profiles